Sign Up to like & get
recommendations!
0
Published in 2017 at "Revista colombiana de psiquiatria"
DOI: 10.1016/j.rcp.2017.06.004
Abstract: INTRODUCTION AND OBJECTIVES Apathy, defined as a deficit for initiating and maintaining action, is a symptom affecting patients with diverse psychiatric and neuropsychiatric diseases, including dementia, sequelae of traumatic brain injury, schizophrenia, depression, and Parkinson's…
read more here.
Keywords:
treatment apathy;
treatment;
systematic review;
pharmacological treatment ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Parkinson's Disease"
DOI: 10.1155/2017/6219851
Abstract: Over 90% of PDD patients show at least one neuropsychiatric symptom (NPS); in the 60–70% two or more NPS are present. Their incidence is important in terms of prognosis and severity of pathology. However, among…
read more here.
Keywords:
rivastigmine;
treatment apathy;
symptomatic treatment;
parkinson dementia ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "PLoS ONE"
DOI: 10.1371/journal.pone.0173872
Abstract: Objective To evaluate the efficacy and safety of bupropion in the treatment of apathy in Huntington’s disease (HD). Methods In this phase 2b multicentre, double-blind, placebo-controlled crossover trial, individuals with HD and clinical signs of…
read more here.
Keywords:
trial;
treatment apathy;
treatment;
bupropion treatment ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2019.01108
Abstract: Background: Apathy is one of the most prevalent neuropsychiatric symptoms encountered in Alzheimer’s disease (AD) and may be an early sign in the development of dementia persisting over the disease course. It has been associated…
read more here.
Keywords:
alzheimer disease;
treatment apathy;
treatment;
disease ... See more keywords